Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New one week radiation treatment for breast cancer patients offers promising results

18.10.2005


A new method of radiation -- accelerated partial breast irradiation using balloon brachytherapy -- makes it more convenient for breast cancer patients to receive radiation therapy after surgery and appears to be safe, offer good cosmetic results, and keep cancer from coming back, according to four-year results of an ongoing study presented October 17, 2005, at the American Society for Therapeutic Radiology and Oncology’s 47th Annual Meeting in Denver.



"This radiation technique is an excellent option for women with early breast tumors, especially those who are unable to have the standard six-week course of radiation, due to time constraints," said Martin Keisch, M.D., lead author of the study and a radiation oncologist at Mount Sinai Comprehensive Cancer Center in Miami Beach, Florida. "There are 100,000 women per year in this country alone that could benefit from this treatment."

Many women with breast cancer are able to undergo breast conserving therapy to keep their breast after treatment. Typically, this means they first have surgery to remove the cancer (a lumpectomy) followed by a course of radiation therapy to kill any cancer cells that may remain. The standard radiation therapy treatment takes a few minutes, every day, Monday through Friday, for five to seven weeks. Radiation oncologists are experimenting with ways to shorten the length of treatment.


During this type of breast brachytherapy, after the tumor has been removed from the breast, the doctor inserts a small balloon into the cavity. That balloon is then attached to a catheter to deliver high doses of radiation to the breast. The treatment reduces the amount of time required for radiation therapy from six weeks to only one. Brachytherapy is one of several methods of accelerated partial breast irradiation, which treats only the area surrounding the tumor, instead of the whole breast.

The multi-center prospective trial involves 43 breast cancer patients who were treated with MammoSite brachytherapy and are being followed over a ten-year period. After a median time of 48 months from treatment, no patients have seen their cancer return and the cosmetic outcome was reported as "good-to-excellent" in 80 percent of the women.

For more information on radiation therapy for breast cancer, please visit www.rtanswers.org.

Dr. Keisch will be presenting the study at 10:15 a.m. on October 17 in Room 205 of the Colorado Convention Center. If you would like a copy of the abstract, "Forty-Eight Month Results with the MammoSite Brachytherapy Applicator: Details Regarding Cosmesis, Toxicity and Local Control in Partial Breast Irradiation" or would like to speak to the lead author of the study, Martin Keisch, M.D., please call Beth Bukata or Nick Lashinsky October 16-20 in the ASTRO Press Room at the Colorado Convention Center at 303-288-8454 or 303-228-8455. You may also e-mail them at bethb@astro.org or nickl@astro.org.

Beth Bukata | EurekAlert!
Further information:
http://www.rtanswers.org
http://www.astro.org.

More articles from Health and Medicine:

nachricht Laser activated gold pyramids could deliver drugs, DNA into cells without harm
24.03.2017 | Harvard John A. Paulson School of Engineering and Applied Sciences

nachricht What does congenital Zika syndrome look like?
24.03.2017 | University of California - San Diego

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>